Paul Clift

Background

About Paul Clift

Experienced Cardiologist specialising in congenital heart disease and aortopathy. Paul has over 20 years experience in managing complex congenital heart disease and has specialist interests in the impact of pulmonary vascular disease on congenital heart disease, the single ventricle circulation and genomic medicine in congenital heart disease. He has published in all these areas and has lectured at numerous national international meetings. He is a clinical trialist, focussing recently on clinical research in the Fontan circulation. He holds the position of Honorary Clinical Senior Lecturer at the University of Birmingham, Institute of Cardiovascular Sciences He is a NIHR CRN National Speciality Lead for Cardiovascular, Chairs the Expert Working Group for Cardiovascular with the National Casemix Team, and is the Clinical Lead for the Centre for Rare Diseases at Queen Elizabeth Hospital in Birmingham. Birmingham has a proud record in research and clinical services for patients with Rare Diseases, and has an integrated service within Birmingham Health Partners, supporting all ages of patients and delivering clinical and translational research. Thoracic aortic dissection is a rare and often lethal condition and Paul has led a medical aortopathy clinic at QEHB for over 10 years, aiming to try and establish the cause of this condition in individuals and screening family members. The service is fully integrated with the QEHB Aortic Surgical Service and the West Midlands Clinical Genetics service Paul is a founding member of the CHAMPION Steering Committee, set up to deliver educational support and clinical research for patients with pulmonary arterial hypertension related to Congenital Heart Disease Paul is a trustee for WhiteSwan Charity, which aims to improve diagnostics and management of hard to diagnose medical conditions through the use of advanced data analytic techniques, follow us at our WhiteSwan LinkedIn page Paul has a clinical interest in sports cardiology and is a member of the Football Association Consensus Group that advises on cardiac screening for young athletes involved in football.